NCT03691493 - Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 8, 2019

Primary Completion Date

October 13, 2022

Study Completion Date

October 13, 2022

Conditions

Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor PositiveHER2/Neu NegativeMetastatic Breast CarcinomaMetastatic Malignant Neoplasm in the BoneProgesterone Receptor PositivePrognostic Stage IV Breast Cancer AJCC v8

Interventions

DRUG

Anastrozole

Given PO

DRUG

Exemestane

Given PO

DRUG

Fulvestrant

Given IM

DRUG

Letrozole

Given PO

DRUG

Palbociclib

Given PO

RADIATION

Radiation Therapy

Undergo radiation therapy

DRUG

Tamoxifen

Given PO

Trial Locations (10)

30303

Grady Health System, Atlanta

30308

Emory University Hospital Midtown, Atlanta

30309

Piedmont Hospital, Atlanta

30322

Emory University Hospital/Winship Cancer Institute, Atlanta

30342

Emory Saint Joseph's Hospital, Atlanta

Northside Hospital, Atlanta

30912

Augusta University Medical Center, Augusta

31405

Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah

31904

John B. Amos Cancer Center, Columbus

04102

Maine Medical Center-Bramhall Campus, Portland